WAVEMAN · COMPANY

ELV · Elevance Health, Inc.

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

ELV

Name: Elevance Health, Inc. (ELV) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Elevance Health, Inc.

INSURANCE · HOSPITAL & MEDICAL SERVICE PLANS · CIK 0001156039

C-SUITE BUYING · 1FORM 144 · 1☆ WATCH

INSIDER NET · 180D

$534.2K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

864

13F, latest reported quarter

REVENUE GROWTH

+12.5%

XBRL, annual

NET MARGIN

2.8%

CONVERSIONS · 180D

codes C/M, not in net · $450.6K priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$534.2K over 180 days

+$1.2M over 90 days

more than 90% of Insurance

CONGRESS

no member of Congress has reported trading it

FUNDS

864 funds added or opened last quarter

more than 94% of Insurance

REVENUE

+12.5% year over year

more than 60% of Insurance

MARGIN

2.8% net margin

below 74% of Insurance

BUYBACKS

$1.4B repurchased, FY to 2026-06-30

more than 90% of Insurance

SHORT

2.6% of shares outstanding short · 3.9 days to cover · settled 2026-07-31

more than 53% of Insurance

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

864 funds added or opened positions in the latest 13F quarter, of 1,613 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +29.1%

+29.1%12M

INSIDER BUYINSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $534.2K bought by insiders over 180 days, 864 funds added last quarter, $629.9K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

GSHD DGICA PLMR ALHC CRVL HGTY KNSL TRV AFL MKL GL OSCR

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Elevance Health, Inc. insiders bought a net $534.2K of stock across 46 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

BOUDREAUX GAIL

President and CEO

BUY

2026-07-17

680.0

$249.2K

BOUDREAUX GAIL

President and CEO

BUY

2026-07-17

2,045.0

$753.1K

PERU RAMIRO G

Director

BUY

2026-07-17

1,000.0

$366.1K

Penczek Ronald W

CAO & Controller

SELL

2026-06-12

369.0

$148.8K

Dixon Robert L JR

Director

SELL

2026-06-11

151.0

$60.7K

46 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 41 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

18,991,090.0 sh

$7.3B

VANGUARD CAPITAL MANAGEMENT LLC

14,058,204.0 sh

$5.4B

STATE STREET CORP

10,426,610.0 sh

$4.0B

WELLINGTON MANAGEMENT GROUP LLP

9,213,513.0 sh

$3.6B

First Eagle Investment Management, LLC

8,376,392.0 sh

$3.2B

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

CLARK R KERRY

FILED 2026-07-07

$629.9K

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Vulcan Value Partners Fund

$16.1M POSITION · AS OF 2026-04-30

6.3%

Select Health Care Services Portfolio

$49.8M POSITION · AS OF 2026-02-28

6.1%

iShares U.S. Healthcare Providers ETF

$31.0M POSITION · AS OF 2026-03-31

4.8%

Sequoia Fund Inc

$155.9M POSITION · AS OF 2026-03-31

4.7%

Artisan Select Equity Fund

$3.9M POSITION · AS OF 2026-03-31

4.6%

PACE Large Co Value Equity Investments

$34.3M POSITION · AS OF 2026-04-30

4.4%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Clinical pipeline

ClinicalTrials.gov · 1 registered trials, 0 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

0 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Government contracts

USASpending.gov · total award ceilings over the contract's life, including awards won through subsidiaries — not annual revenue

Department Of Health And Human Services

J6 A/B MAC SERVICES · 2020-08-01

$565.5M

Department Of Health And Human Services

PART A/PART B MEDICARE ADMINISTRATIVE CONTRACTOR (MAC) JURISDICTION K (JK) · 2022-01-01

$483.6M

Department Of Health And Human Services

SPARC WILL BE THE MAJOR CONTRACT VEHICLE FOR CMS IT SYSTEMS AND SUPPORT HHS OPDIVS CAN ALSO MAKE USE · 2025-01-27

$21.8M

Department Of Health And Human Services

THE CONTRACTOR SHALL PROVIDE SUPPLIES AND/OR SERVICES TO PROVIDE A SINGLE FRONT-END SOLUTION FOR THE · 2022-08-11

$20.0M

FEDERAL AWARDS ≥ $25M IN THE LAST 90 DAYS · MATCHED VIA SAM.GOV PARENT REGISTRY

Corporate PAC

FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors

Elevance Health, Inc. Political Action Committee (Elevance Health Pac)

CYCLE 2026 · $2,528K SPENT

$2.2M

FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION

Executive pay vs shareholder return · Gail Boudreaux

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2025

$22.6M

$18.8M

$7.2M

+17%

+48%

2024

$20.5M

-$4.0M

$6.3M

+21%

+29%

2023

$21.9M

$16.2M

$8.9M

+52%

+26%

2022

$20.9M

$35.3M

$6.7M

+63%

+24%

2021

$19.3M

$50.4M

$6.4M

+46%

+26%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$199.1B	$177.0B	$171.3B	$156.6B
OPERATING INCOME	$7.2B	$7.9B	$8.5B	$8.3B
NET INCOME	$5.7B	$6.0B	$6.0B	$5.9B
EPS (DILUTED)	25.21	25.68	25.22	24.28
OPERATING CASH FLOW	$4.3B	$5.8B	$8.1B	$8.4B
CASH	$9.5B	$8.3B	$6.5B	$7.4B
LONG-TERM DEBT	$30.8B	$29.2B	$23.2B	$22.3B
BUYBACKS	$2.6B	$2.9B	$2.7B	$2.3B
DIVIDENDS PAID	$1.5B	$1.5B	$1.4B	$1.2B

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE